S Tani Selected Research

Coloring Agents (Dyes)

1/2001

Vascular orientation by intra-arterial dye injection during spinal arteriovenous malformation surgery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Tani Research Topics

Disease

2	Aneurysm (Aneurysms) 01/2020 - 03/2009
2	T-Cell Lymphoma (Lymphoma, T Cell) 09/2001 - 09/2001
2	Neoplasms (Cancer) 07/2001 - 01/2001
1	Rupture 01/2020
1	Viremia 01/2018
1	Achlorhydria (Hypochlorhydria) 01/2018
1	Blister (Bulla) 06/2017
1	Bullous Pemphigoid (Pemphigoid) 06/2017
1	Stomach Ulcer (Gastric Ulcer) 04/2016
1	Ulcer 04/2016
1	Hematoma 03/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2001
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2001
1	Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula) 01/2001
1	Atherosclerotic Plaque (Atheroma) 08/2000
1	Diabetes Mellitus 04/2000
1	Type 2 Diabetes Mellitus (MODY) 04/2000

Drug/Important Bio-Agent (IBA)

2	prenylIBA 07/2001 - 01/2001
1	UreaseIBA 01/2018
1	AutoantibodiesIBA 06/2017
1	CollagenIBA 06/2017
1	Immunoglobulin G (IgG)IBA 06/2017
1	CytokinesIBA 04/2016
1	prolyl-glycyl-prolineIBA 04/2016
1	Acetic Acid (Vinegar)FDA LinkGeneric 04/2016
1	Messenger RNA (mRNA)IBA 04/2016
1	5-ethyl-2,2'-anhydrouridineIBA 03/2009
1	KetonesIBA 11/2001
1	Verapamil (Calan)FDA LinkGeneric 09/2001
1	Methanol (Carbinol)IBA 09/2001
1	GenisteinIBA 07/2001
1	IsoflavonesIBA 07/2001
1	Indigo Carmine (Indigo Blue)IBA 01/2001
1	Coloring Agents (Dyes)IBA 01/2001
1	FlavanonesIBA 01/2001
1	StilbenesIBA 01/2001
1	ResveratrolIBA 01/2001
1	Thromboplastin (Tissue Factor)IBA 08/2000
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2000
1	Erythromycin (Erycette)FDA LinkGeneric 04/2000

Therapy/Procedure

2	Therapeutics 01/2018 - 01/2018
1	Retreatment 01/2020
1	Intranasal Administration 04/2016